DRUG

dacomitinib

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for dacomitinib

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
EGFR pancreatic ductal adenocarcinoma 0.208 Mid partial evidence none

Clinical trials

65 registered trials for dacomitinib

Source: ClinicalTrials.gov

← All drugs